Compared to bare-metal stents (BMSs), drug-eluting stents (DESs) have been regarded as a
revolutionary change in coronary artery diseases (CADs). Releasing pharmaceutical agents …

Coronary artery aneurysms (CAAs) are uncommon and describe a localized dilatation of a
coronary artery segment more than 1.5-fold compared with adjacent normal segments. The …

Background: Glucocorticoids have adverse systemic effects, including obesity, hypertension,
and hyperglycemia, that may predispose to cardiovascular disease. The effect of …

Chronic excessive activation of glucocorticoid receptors induces obesity, insulin resistance,
glucose intolerance, dyslipidaemia and hypertension. Subtle abnormalities of the …

Background Vascular interventions that maximize initial lumen diameter provoke extensive
neointimal hyperplasia but minimize its effects, causing long-term lumen size to be greater …

Background Colchicine has unique anti-inflammatory properties that may be beneficial in
various cardiovascular conditions. This systematic review and meta-analysis of randomized …

Drug-eluting stents (DES), which locally elute antiproliferative drugs, can dramatically inhibit
neointimal growth. However, several pathological studies have indicated that DES may …

Objectives: This study sought to assess clinical, angiographic, and intravascular ultrasound
(IVUS) findings in patients develo** coronary aneurysms (CANs) after drug-eluting stent …

Background—Sirolimus-eluting stents (SESs) reduce angiographic restenosis in patients
with focal, native coronary artery stenoses. This study evaluated the usefulness of SESs in …

OBJECTIVES: To assess the association between cardiovascular (CV) risk and low-dose
corticosteroids (LD-CT, defined as a daily dose< 10mg/day of prednisone) in rheumatoid …